Literature DB >> 1675153

Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.

M R Young1, M A Wright, M E Young.   

Abstract

Progressive growth of metastatic Lewis lung carcinoma (LLC) tumors results in a concurrent stimulation of myelopoiesis and the appearance of immune-suppressive bone marrow cells. The present study has shown that normal bone marrow cells could be induced to become immune-suppressive by 3 days of culture with supernatants of cloned metastatic LLC-LN7 variant cells. The capacity of the LLC-LN7 supernatants to stimulate the appearance of suppressor cells was directly proportional to the concentration of supernatant used in the bone marrow culture. When adoptively transferred with a LLC-LN7 tumor inoculum, the supernatant-induced suppressor bone marrow cells increased the rate of appearance of palpable tumors and the frequency of tumor establishment. The LLC-LN7 supernatants containing suppressor-cell-inducing activity also had colony-stimulating factor (CSF) activity. The CSF activity produced by the LLC-LN7 cells could be diminished with neutralizing antibodies to either granulocyte/monocyte(GM-) CSF or to interleukin-3 (IL-3). Likewise, the suppressor-inducing activity in the LLC-LN7 supernatants was diminished by pretreatment with anti-GM-CSF or anti-IL-3. The combination of anti-GM-CSF and anti-IL-3 completely neutralized all suppressor-inducing activity produced by the LLC-LN7 cells. These results suggest that the secretion of IL-3 and GM-CSF by LLC-LN7 tumor cells is a mechanism by which the tumors stimulate myelopoiesis and induce normal bone marrow cells to become immune-suppressive. Bone marrow cells that are induced to become immune-suppressive by culture with LLC-LN7 supernatants can, in turn, facilitate the establishment of tumor in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675153     DOI: 10.1007/bf01756134

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  31 in total

1.  Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.

Authors:  K Itoh; N R Pellis; C M Balch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.

Authors:  Y Tsuchiya; M Igarashi; R Suzuki; K Kumagai
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

3.  Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.

Authors:  P D Smith; C L Lamerson; H L Wong; L M Wahl; S M Wahl
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

4.  Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor.

Authors:  M Sabatini; J Chavez; G R Mundy; L F Bonewald
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

5.  Human granulocyte-macrophage colony-stimulating factor plus phorbol myristate acetate stimulate a promyelocytic cell line to produce an IL-1 inhibitor.

Authors:  G J Mazzei; L M Bernasconi; C Lewis; J J Mermod; V Kindler; A R Shaw
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

6.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  Stimulation of hematopoiesis and bone marrow suppressor cells by the subcutaneous injection of linoleic acid.

Authors:  M R Young; N K Ellis; M E Young; H T Wepsic
Journal:  Cell Immunol       Date:  1987-06       Impact factor: 4.868

8.  Role of asialo-GM1 positive liver cells from athymic nude or polyinosinic-polycytidylic acid-treated mice in suppressing colon-derived experimental hepatic metastasis.

Authors:  S A Cohen; S P Tzung; R J Doerr; M H Goldrosen
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

9.  Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.

Authors:  M R Young; S Aquino; M E Young
Journal:  J Leukoc Biol       Date:  1989-03       Impact factor: 4.962

10.  Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

Authors:  R J North
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

View more
  14 in total

1.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

Authors:  V Bronte; E Apolloni; A Cabrelle; R Ronca; P Serafini; P Zamboni; N P Restifo; P Zanovello
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta.

Authors:  M R Young; M A Wright; M Coogan; M E Young; J Bagash
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 3.  Dendritic cells and tumor microenvironment: a dangerous liaison.

Authors:  Ingo Fricke; Dmitry I Gabrilovich
Journal:  Immunol Invest       Date:  2006       Impact factor: 3.657

Review 4.  Subsets, expansion and activation of myeloid-derived suppressor cells.

Authors:  Eliana Ribechini; Verena Greifenberg; Sarah Sandwick; Manfred B Lutz
Journal:  Med Microbiol Immunol       Date:  2010-04-08       Impact factor: 3.402

Review 5.  Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer.

Authors:  Sergei Kusmartsev; Dmitry I Gabrilovich
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

6.  Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.

Authors:  M R Young; G McCloskey; M A Wright; A S Pak
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

7.  Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence.

Authors:  M R Young; J Ihm; Y Lozano; M A Wright; M M Prechel
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

Review 8.  Eicosanoids and the immunology of cancer.

Authors:  M R Young
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

Review 9.  History of myeloid-derived suppressor cells.

Authors:  James E Talmadge; Dmitry I Gabrilovich
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 10.  Targeting tumor-stromal interactions in bone metastasis.

Authors:  Mark Esposito; Yibin Kang
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.